Badillo-Tenorio RE, Rivas-Larrauri FE

Language: Spanish
References: 18
Page: 353-357
PDF size: 361.50 Kb.

ABSTRACT

Systemic lupus erythematosus (SLE) is a chronic autoinmune multisystemic disease. Intravenous immunoglobulins (IVIg) have been previously used for the treatment of primary immunodeficiency diseases. In addition IVIg is used for a few autoimmune diseases, such as immune thrombocytopenic purpura. IVIg is an immunomodulatory agent capable of modulating autoinmunity and also provide defense against infection, IVIg has been used successfully in SLE. We review the role of IVIg in SLE as a therapeutic option.

REFERENCES

1. Benedek T. Historical background of discoid and systemic erythematosus lupus. En: Wallace. Bevra. Han. Dubois’ lupus erythematosus. Wallace D. Bevra. Han. 7a Ed. USA: Lippincott Williams & Wilkins; 2007. p. 2-13.

2. Berrón R. Enfermedades autoinmunitarias en el niño. Lupus Eritematoso Sistémico. México: Editorial Alfil; 2007;(3):19-43.

3. Kalunian, Tutuncu ZN, KC. The definition and classification of systemic lupus erythematosus. En: Wallace. Bevra. Han. Dubois’ lupus erythematosus. Wallace D. Bevra. Han. 7a Ed. USA: Lippincott Williams & Wilkins; 2007. p. 16-20.

4. Levy DM, Kamphuis S. Systemic lupus erythematosus in children and adolescents. Pediatr Clin North Am. 2012;59:345-364.

5. Blanca-Galicia B, Guevara-Cruz M, Berrón-Pérez R, Berrón- Ruiz L, Gutiérrez-Castrellón P, Espinoza-Rosales FJ. Survival of Mexican patients with paediatric-onset systemic lupus erythematosus and abnormal electroencephalogram. Allergol Immunopathol (Madr). 2012;41:108-113.

6. Pickering G. Treatment of systemic lupus erythematosus with steroids. Br Med J. 1961;7:915-920.

7. Pyne DM. Ehrenstein, V. Morris. The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases. Rheumatol. 2002;41:367-374.

8. Jolles S, Sewells WAC, Misbah SA. Clinical uses of intravenous immunoglobulin. Clin Exper Immunol. 2005;142:1-11.

9. Rahman A, Isenberg D. Mechanisms of disease systemic lupus erythematosus. N Engl J Med. 2008;358:929-939.

10. Marier WP, Gordon DS, Howard RF, Saleh MN, Miller SB, Lieberman JD, Woodlee PM. Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia. Arthr Rheum. 1990;33:1233-1239.

11. Levy Y, Sherer Y, Ahmed A, Langevitz P, Geroge J, Fabrizzi F, Terryberry J, Meissner M, Lorber M, Peter JB, Shoenfeld Y. A study of 20 SLE patients with intravenous immunoglobulin– clinical and serologic response. Lupus. 1999;8:705-712.

12. Francioni C, Galeazzi M, Fioravanti A, Gelli R, Megale F, Marcolongo R. Long-term i.v. Ig treatment in systemic lupus erythematosus. Clin Exp Rheumatol. 1994;12:163-168.

13. Schroeder MD, Zeuner RA, Euler HH, Loffler H. High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serogical results of a pilot study. J Rheumatol. 1996;23:71-75.

14. Yong PF, Aslam L, Karim MY, Khamashta MA. Management of hypogammaglobulinaemia occurring in patients with systemic lupus erythematosus. Rheumatol (Oxford). 2008;47:1400- 1405.

15. Yamazaki-Nakashimada M, Duran-McKinster C, Ramírez- Vargas N, Hernández-Bautista V. Intravenous inmunoglobulin therapy for hypocomplementemic urticarial vasculitis associated with systemic lupus erythematosus in a child. Pediatr Dermatol. 2009;26:445-447.

16. Yamazaki-Nakashimada MA, Rodríguez-Jurado R, Ortega- Salgado A, Gutiérrez-Hernández A, García-Pavón-Osorio S, Hernández-Bautista V. Intestinal pseudoobstruction associated with eosinophilic enteritis as the initial presentation of systemic lupus erythematosus in children. J Pediatr Gastroenterol Nutr. 2009;48:482-486.

17. Hernández-Bautista VM, Stamatelos-Albarrán D, Vázquez- García RE, Martínez-Borja LM, Rodríguez-Lozano AL. Lupus and autoimmune shock: Use of intravenous gammaglobulin. Case report and proposal for a new designation. Acta Pediatr Mex. 2013;34:81-84.

18. Karim MY, Pisoni CN, Khamashta MA. Update on immunotherapy for systemic lupus erythematosus? What´s hot and what´s not! Rheumatol. 2009;48:332-341.